These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 766041)

  • 41. The clinical efficacy and side-effects of mianserin and nortriptyline in depressed out-patients: a double-blind randomized trial.
    Hoc J
    Curr Med Res Opin; 1982; 8(4):282-9. PubMed ID: 6759061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term treatment of endogenous depression with nortriptyline with control of plasma levels.
    Kragh-Sorensen P; Hansen CE; Larsen NE; Nasestoft J; Hvidberg EF
    Psychol Med; 1974 May; 4(2):174-80. PubMed ID: 4208380
    [No Abstract]   [Full Text] [Related]  

  • 43. Tricyclic plasma levels in depressed outpatients treated with amitriptyline.
    Rickels K; Weise C; Case G; Hucker H
    Psychopharmacology (Berl); 1983; 80(1):14-8. PubMed ID: 6408663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three-year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levels.
    Reynolds CF; Perel JM; Frank E; Cornes C; Miller MD; Houck PR; Mazumdar S; Stack JA; Pollock BG; Dew MA; Kupfer DJ
    Am J Psychiatry; 1999 Aug; 156(8):1177-81. PubMed ID: 10450257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlations between serum ami- and nortriptyline concentrations and psychomotor performance.
    Seppälä T; Liljequist R; Linnoila M; Overo KF; Dorrity F
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):472-80. PubMed ID: 579558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic aspects on once-daily nortriptyline administration.
    Overø KF
    Neuropsychobiology; 1980; 6(1):34-41. PubMed ID: 7366812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sampling time, dosage schedule, and nortriptyline plasma levels.
    Ziegler VE; Knesevich JW; Wylie LT; Biggs JT
    Arch Gen Psychiatry; 1977 May; 34(5):613-5. PubMed ID: 871235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial.
    Watson CP; Vernich L; Chipman M; Reed K
    Neurology; 1998 Oct; 51(4):1166-71. PubMed ID: 9781549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
    Vandel S; Bertschy G; Jounet JM; Allers G
    Ther Drug Monit; 1988; 10(4):386-9. PubMed ID: 3144066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study.
    Coppen A; Ghose K; Montgomery S; Rama Rao VA; Bailey J; Christiansen J; Mikkleson PL; van Praag HM; van de Poel F; Minsker EJ; Kozulja VG; Matussek N; Kungkunz G; Jłrgensen A
    Lancet; 1978 Jan; 1(8055):63-6. PubMed ID: 74566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific radioimmunoassay for amitriptyline and nortriptyline in plasma.
    Lucek R; Dixon R
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):125-36. PubMed ID: 905625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma prolactin during treatment with nortriptyline.
    Nielsen JL
    Neuropsychobiology; 1980; 6(1):52-5. PubMed ID: 7366815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in effect between nomifensine and nortriptyline.
    Pöldinger W; Gammel G
    Int Pharmacopsychiatry; 1978; 13(1):58-68. PubMed ID: 342438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients.
    Jungkunz G; Kuss HJ
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):111-6. PubMed ID: 7393997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A sequential trial comparing two plasma levels of nortriptyline.
    Burrows G; Turecek LR; Davies B; Mowbray R; Scoggins BA
    Aust N Z J Psychiatry; 1974 Mar; 8(1):21-3. PubMed ID: 4606144
    [No Abstract]   [Full Text] [Related]  

  • 56. Correlation of subjective side effects with plasma concentrations of nortriptyline.
    Asberg M; Cronholm B; Sjöqvist F; Tuck D
    Br Med J; 1970 Oct; 4(5726):18-21. PubMed ID: 5470429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of a therapeutic plasma level range in amitriptyline treatment of depression.
    Breyer-Pfaff U; Giedke H; Gaertner HJ; Nill K
    J Clin Psychopharmacol; 1989 Apr; 9(2):116-21. PubMed ID: 2723128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma-nortriptyline levels in depression.
    Rifkin AE; Quitkin FM; Klein DF
    Lancet; 1973 Jun; 1(7814):1258. PubMed ID: 4122613
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder.
    Geller B; Cooper TB; Graham DL; Fetner HH; Marsteller FA; Wells JM
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):34-44. PubMed ID: 1537779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.
    Dahl ML; Bertilsson L; Nordin C
    Psychopharmacology (Berl); 1996 Feb; 123(4):315-9. PubMed ID: 8867869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.